Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 25, 1995 - Issue 11
18
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Absorption, tissue distribution, metabolism and excretion of ormetoprim and sulphadimethoxine in Atlantic salmon (Salmo salar) after intravenous and oral administration of Romet30

, &
Pages 1169-1180 | Received 11 May 1995, Published online: 22 Sep 2008
 

Abstract

1. Uptake, bioavailability, tissue disposition and elimination of sulphadimethoxine (SDM) and ormetoprim (OMP) were examined in Atlantic salmon (Salmo salar) following intravenous and oral administration of Romet30 at a dose of 5 mg OMP and 25 mg SDM kg-1 fish.

2. Plasma clearance was rapid for both drugs following a single i.v. dose, characterized by t1/2α = 0.48 and 0.54h, t1/2β = 9.9 and 25.6h for SDM and OMP respectively with a volume of distribution (Vss) = 0.389 and 2.4781kg-1.

3. Following oral administration, peak plasma concentrations of 1.13 and 9.99μgml-1 were achieved after 17.6 and 20.3h for OMP and SDM respectively. Bioavailabilities were 85% for OMP and 39% for SDM.

4. Oral administration revealed the highest concentration of OMP in kidney and liver whereas the highest concentrations of SDM were found in muscle and bile.

5. High concentrations of N4-acetylated SDM were found in the bile indicating significant metabolism of SDM.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.